Clinical Trial

Multimodality Imaging in the Screening, Diagnosis and Risk StratifictiON of HFpEF

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 8, 2022 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The incidence of Heart failure with preserved ejection fraction (HFpEF) in Heart failure patients increases rapidly. However, the current clinical awareness is insufficient, and the cardiac structural and functional injury are not well understood. It is difficult to recognize the subclinical changes of the cardiac in the early stage with conventional imaging techniques, and it is common to ignore the existence of the clinical alterations. This study aimed to investigate the cardiac features, early diagnosis and risk factors of HFpEF patients, based on the multi-modal (Magnetic resonance imaging- nuclear medicine imaging- echocardiography) imaging, combined with large data and artificial intelligence. This study will provide deep insights into the HFpEF derived from different causes.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2020-10-20; most recent amendment 2022-11-05.
Status change: Not Yet Recruiting → Recruiting 2021-02-01
Trial Details
NCT Number NCT04603404
Lead Sponsor Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions Heart Failure, Diastolic
Enrollment 430 participants
Start Date 2019-01-01
Primary Completion 2025-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2022-11-08